Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2150140)

Published in Br J Cancer on April 01, 1998

Authors

K F Yoong1, D H Adams

Author Affiliations

1: Liver Research Laboratories, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Articles citing this

Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol (1999) 1.25

Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells. Clin Dev Immunol (2012) 0.95

T cell responses against tumor associated antigens and prognosis in colorectal cancer patients. J Transl Med (2005) 0.92

Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection. Immunology (2001) 0.91

Adhesion of lymphocytes to hepatic endothelium. Mol Pathol (1999) 0.87

Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br J Cancer (2001) 0.87

A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells. Gut (2005) 0.83

Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis. Clin Diagn Lab Immunol (2004) 0.81

T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches. Br J Cancer (2003) 0.80

Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br J Cancer (2006) 0.79

The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease. Br J Cancer (2001) 0.78

Articles cited by this

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst (1994) 7.20

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell (1992) 5.67

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (1993) 5.30

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med (1996) 3.56

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48

Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today (1996) 2.42

Co-stimulation in T cell responses. Curr Opin Immunol (1997) 2.35

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol (1986) 1.74

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol (1995) 1.67

Human tumor antigens recognized by T cells. Curr Opin Immunol (1996) 1.54

Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol (1994) 1.32

Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol (1995) 1.25

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann Surg Oncol (1996) 1.23

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. J Immunol Methods (1991) 1.18

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer (1995) 1.17

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol (1993) 1.08

Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res (1994) 1.08

T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today (1995) 1.07

The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer (1996) 0.99

Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells. J Immunol Methods (1988) 0.99

Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother (1995) 0.98

Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology (1996) 0.96

Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer (1988) 0.94

The uptake and retention of chromium by cells. Transplantation (1976) 0.93

Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers. J Immunol (1996) 0.88

Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer (1990) 0.87

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur J Immunol (1995) 0.87

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis. Br J Cancer (1997) 0.85

Resectability of large focal liver lesions. Br J Surg (1989) 0.83

ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma. J Surg Res (1996) 0.81

Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy. Surgery (1995) 0.80

T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor. Int J Cancer (1994) 0.77

Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications. Clin Mol Pathol (1996) 0.77

Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma. Cancer Immunol Immunother (1995) 0.77

Management of recurrent and metastatic colorectal carcinoma. Surg Clin North Am (1993) 0.76

Articles by these authors

(truncated to the top 100)

T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature (1993) 4.57

Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation (1996) 4.40

Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann Surg (1997) 2.86

Pneumopericardium resulting in cardiac tamponade. Ann Thorac Surg (1984) 2.62

Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol (1999) 2.61

Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today (1993) 1.94

Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg (1999) 1.87

Neurological complications following liver transplantation. Lancet (1987) 1.76

Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol (2001) 1.66

Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci U S A (1993) 1.61

Single-clamp technique: an important adjunct to myocardial and cerebral protection in coronary operations. Ann Thorac Surg (1994) 1.61

Axilloaxillary cardiopulmonary bypass: a practical alternative to femorofemoral bypass. Ann Thorac Surg (1997) 1.57

The infective process in scrapie. Lancet (1968) 1.56

Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation (2001) 1.56

Non-steroidal anti-inflammatory drugs and renal failure. Lancet (1986) 1.52

Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med (1993) 1.49

MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology (2001) 1.47

Assessment and management of functional or ischaemic mitral regurgitation. Lancet (2000) 1.45

10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol (1991) 1.42

Fresh porcine cardiac valves are not rejected in primates. J Thorac Cardiovasc Surg (2000) 1.42

Cerebral aspergillosis in liver transplantation. J Clin Pathol (1990) 1.40

Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol (2006) 1.39

CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med (1999) 1.39

Is HLA matching important for liver transplantation? J Hepatol (1990) 1.39

CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol (2000) 1.35

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci U S A (1990) 1.34

Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol (1998) 1.33

Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol (1998) 1.29

The natural history and recommended management of patients with traumatic coronary artery fistulas. Ann Thorac Surg (1983) 1.28

Liposome toxicity in the mouse central nervous system. J Neurol Sci (1977) 1.26

Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 1.25

Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol (1999) 1.25

Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation (2001) 1.24

Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol (1998) 1.20

Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development. J Exp Med (1994) 1.18

Reoperative aortic valve replacement: partial upper hemisternotomy versus conventional full sternotomy. J Thorac Cardiovasc Surg (1999) 1.16

Chronic rejection--an undefined conundrum. Transplantation (1991) 1.14

Repair of mitral regurgitation from myxomatous degeneration in the patient with a severely calcified posterior annulus. J Card Surg (1995) 1.14

Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology (1999) 1.14

The preferred approach for mitral valve surgery after CABG: right thoracotomy, hypothermia and avoidance of LIMA-LAD graft. J Heart Valve Dis (2001) 1.09

CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol (1994) 1.09

The relationship between cellular nucleic acids in the developing rat cerebral cortex. Biochem J (1966) 1.08

CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J (2001) 1.07

Validated age, growth and maturity of the bonnethead Sphyrna tiburo in the western North Atlantic Ocean. J Fish Biol (2014) 1.06

Mitral valve surgery after previous CABG with functioning IMA grafts. Ann Thorac Surg (1999) 1.06

Gallbladder polyps: when to wait and when to act. Lancet (1997) 1.06

Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut (1999) 1.05

Reduced mortality and morbidity for ascending aortic aneurysm resection regardless of cause. Ann Thorac Surg (1996) 1.05

Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology (2000) 1.04

Collagen loss and impaired wound healing is associated with c-Myb deficiency. J Pathol (2007) 1.04

Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology (1996) 1.03

Minimally invasive aortic valve replacement. Semin Thorac Cardiovasc Surg (1997) 1.01

Transmission of agent of Creutzfeldt-Jakob disease. Br Med J (1978) 1.00

Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians (1997) 1.00

Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut (1993) 0.99

The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg (1995) 0.98

Decrease in operative risk of reoperative valve surgery. Ann Thorac Surg (1993) 0.98

Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol (1995) 0.98

The incorporation of (3H) thymidine and (14C) glucosamine into a DNA-polysaccharide complex in normal and scrapie-affected mouse brain. Arch Gesamte Virusforsch (1970) 0.98

The homogeneity and protein composition of rat brain myelin. Brain Res (1969) 0.98

Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist. Br J Anaesth (2008) 0.97

Cyclosporin-associated cerebral lesions in liver transplantation. Lancet (1988) 0.97

Mitral valve repair in cardiomyopathy. Circulation (1998) 0.97

Flightless I deficiency enhances wound repair by increasing cell migration and proliferation. J Pathol (2007) 0.95

Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection. J Antimicrob Chemother (1985) 0.94

Automated distal coronary bypass with a novel magnetic coupler (MVP system). J Thorac Cardiovasc Surg (2004) 0.93

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens. Br J Cancer (2006) 0.92

Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut (2006) 0.92

Isolated left atrial tamponade following circumflex artery angioplasty. Heart (2000) 0.92

Modulation of cytokine function by heparan sulfate proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc Assoc Am Physicians (1998) 0.92

Studies on the properties of factors elevating the activity of mouse-plasma lactate dehydrogenase. Biochem J (1964) 0.91

Disseminated intravascular coagulation caused by abdominal aortic aneurysm. J Vasc Surg (1986) 0.91

Understanding selective trafficking of lymphocyte subsets. Gut (2002) 0.90

Partial upper re-sternotomy for aortic valve replacement or re-replacement after previous cardiac surgery. Eur J Cardiothorac Surg (2000) 0.90

Monitoring pig-to-primate cardiac xenografts with live Internet images of recipients and xenograft telemetric signals: histologic and immunohistochemical correlations. J Heart Lung Transplant (2000) 0.90

Orthotopic liver transplantation: postoperative complications and their management. Br J Surg (1987) 0.89

Lymphocyte homing to allografts. Transplantation (2000) 0.89

Rapid noninvasive diagnosis and surgical repair of acute ascending aortic dissection. Improved survival with less angiography. J Thorac Cardiovasc Surg (1994) 0.88

The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000. Ann Thorac Surg (1999) 0.88

Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut (2005) 0.88

The long-term results of mitral valve reconstruction for the "floppy" valve. J Card Surg (1994) 0.88

Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience (2005) 0.88

Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension. Circulation (1983) 0.88

Aortic valve endocarditis. Determinants of early survival and late morbidity. Circulation (1994) 0.88

Adhesion of lymphocytes to hepatic endothelium. Mol Pathol (1999) 0.87

Aetiology of multiple sclerosis. Lancet (1974) 0.87

Neuropathological findings in autopsies after liver transplantation. Transplant Proc (1991) 0.87

Minimally invasive direct access heart valve surgery. J Card Surg (2001) 0.86

Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation (1999) 0.86

Central pontine myelinolysis in liver transplantation. J Clin Pathol (1991) 0.86

Femoral veno-arterial extracorporeal life support with minimal or no heparin. Ann Thorac Surg (1993) 0.86

Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation (1995) 0.86

Inflammatory cytokines stimulate human biliary epithelial cells to express interleukin-8 and monocyte chemotactic protein-1. Biochem Soc Trans (1997) 0.85

Amino acid incorporation by preparations from the developing rat brain. Biochem J (1966) 0.85

Foveal cone function in nonproliferative diabetic retinopathy and macular edema. Invest Ophthalmol Vis Sci (1997) 0.85

Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut (1992) 0.85

Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation (1993) 0.85

Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg (1998) 0.84

Studies on DNA from normal and scrapie-affected mouse brain. J Neurochem (1972) 0.84

Transesophageal echocardiographic diagnosis of acute aortic valve insufficiency after mitral valve repair. Anesth Analg (2000) 0.84